贝达药业：已预约2026年4月23日披露2025年年度报告

Core Viewpoint - The company, Betta Pharmaceuticals (300558.SZ), confirmed that its operations are normal and there are no regulatory requirements to issue a performance forecast [2] Group 1 - The company has scheduled to disclose its 2025 annual report on April 23, 2026, and encourages stakeholders to pay attention to the relevant announcements [2]